To confirm the clinicopathological role of the TIP30 mRNA expression level in NSCLC patients, we performed a meta-analysis using 3 microarray datasets with 11 probes for the relapse-free survival of lung cancer patients. The gene discussed is HTATIP2; the disease is non-small cell lung carcinoma.